Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors.
Serino M, Freitas C, Martins M, Ferreira P, Cardoso C, Veiga F, Santos V, Araújo D, Novais-Bastos H, Magalhães A, Queiroga H, Fernandes G, Hespanhol V.
Serino M, et al. Among authors: fernandes g.
Pulmonology. 2022 Apr 9:S2531-0437(22)00076-9. doi: 10.1016/j.pulmoe.2022.03.003. Online ahead of print.
Pulmonology. 2022.
PMID: 35414494
Free article.